International Flavors & Fragrances Inc (IFF) has been turning heads in the recent past. Seen as a top pick in Carl Icahn’s Stock Portfolio, the company has attracted new investors, including Maverick Capital Ltd and Lighthouse Investment Partners LLC, among others. Even though EU fined IFF for obstructing a fragrance cartel investigation, the group's bullish trend prevails. The company's innovative strides, notably in pharma solutions, brought it in spotlight at CPhI 2024. IFF's share price has also shown positive momentum, with a 54% gain reported for those who invested a year ago. A notable development was IFF's deal to sell its pharma unit to France's Roquette for $2.85 billion. Variety of investors continue to boost their stakes in IFF indicating strong future prospects. Notably, institutional owners hold 87% of the company indicating trust and belief in the firm's potential. However, there were challenges and contrarian views as well, with the group's dividend being reduced. Despite a few setbacks, the company reported higher volumes in Q2 earnings and topped on expectations.
International Flavors Fragrances IFF News Analytics from Mon, 23 Oct 2023 07:00:00 GMT to Sun, 29 Sep 2024 12:21:54 GMT - Rating 7 - Innovation 6 - Information 8 - Rumor -2
